TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 255 filers reported holding TG THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $149,026 | -66.4% | 17,826 | -0.1% | 0.00% | -100.0% |
Q2 2023 | $443,319 | +88.0% | 17,847 | +13.8% | 0.00% | 0.0% |
Q1 2023 | $235,767 | +16.4% | 15,676 | -8.5% | 0.00% | 0.0% |
Q4 2022 | $202,636 | +132.9% | 17,129 | +16.6% | 0.00% | – |
Q3 2022 | $87,000 | +35.9% | 14,686 | -1.9% | 0.00% | – |
Q2 2022 | $64,000 | -72.3% | 14,963 | -38.4% | 0.00% | – |
Q1 2022 | $231,000 | -57.0% | 24,295 | -14.1% | 0.00% | -100.0% |
Q4 2021 | $537,000 | -1.8% | 28,297 | +72.2% | 0.00% | -50.0% |
Q3 2021 | $547,000 | -57.6% | 16,428 | -50.6% | 0.00% | -50.0% |
Q2 2021 | $1,290,000 | -17.8% | 33,256 | +2.2% | 0.00% | -20.0% |
Q1 2021 | $1,569,000 | +18.1% | 32,545 | +27.4% | 0.01% | 0.0% |
Q4 2020 | $1,328,000 | +264.8% | 25,538 | +87.6% | 0.01% | +150.0% |
Q3 2020 | $364,000 | +42.2% | 13,613 | +3.7% | 0.00% | +100.0% |
Q2 2020 | $256,000 | +96.9% | 13,128 | +12.4% | 0.00% | 0.0% |
Q4 2019 | $130,000 | +21.5% | 11,682 | +2.1% | 0.00% | 0.0% |
Q2 2014 | $107,000 | -1.8% | 11,442 | -27.3% | 0.00% | 0.0% |
Q1 2014 | $109,000 | – | 15,738 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
Parkwood LLC | 165,414 | $6,081 | 0.66% |
Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |